Author

Jean Helmijr

Erasmus MCORCID 0000-0003-0983-6296Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:whole-genome sequencing· 2 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Research Focus:variant calling· 1

Frequent Co-Authors

John W.M. MartensiD· 2 shared Anouk C. de JongiD· 1 shared Chris J. de WitteiD· 1 shared Christina Stangl· 1 shared Cornelis Kees VerhoefiD· 1 shared Daan M. HazelaariD· 1 shared Henk M.W. VerheuliD· 1 shared Ivo Renkens· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

John W.M. MartensORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Bioinformaticsnpj Precision OncologyPeer-reviewedDec 15, 2025

Improved circulating tumor DNA profiling by simultaneous extraction of DNA methylation and copy number information from Methylated DNA Sequencing data (MeD-seq)

Daan M. Hazelaar, Ruben Boers, Joachim Boers…·Saskia M. Wilting

The paper introduces MeD-seq, a method to profile circulating tumor DNA by analyzing DNA methylation and copy number changes, showing its effectiveness in detecting cancer-specific signals in plasma samples.

3 citations

humanDNA methylation

𝕏 PostBluesky

Genetic & Genomic MedicineGenome MedicinePeer-reviewedMay 18, 2021

Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring

Jose Espejo Valle-Inclán, Christina Stangl, Anouk C. de Jong…·Wigard P. Kloosterman

SHARC rapidly identifies somatic genomic structural variations from nanopore sequencing for blood-based cancer monitoring, detecting ten SVs per sample and enabling treatment response tracking in metastatic prostate cancer.

46 citationstop 4%

humanwhole-genome sequencing

𝕏 PostBluesky